Metformin Hydrochloride

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling changes for metformin hydrochloride; regulatory action does not report clinical trial outcomes or efficacy data.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for metformin hydrochloride labeling; it documents a regulatory decision, not clinical trial evidence.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling changes for an existing metformin hydrochloride extended-release product; no clinical trial data or efficacy evidence is reported.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for metformin hydrochloride labeling; it documents a regulatory decision, not clinical trial evidence.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling changes for metformin hydrochloride extended-release tablets; this is a regulatory action record, not a clinical trial, and does not contain efficacy or safety data.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for metformin hydrochloride labeling change; regulatory action with no clinical trial data reported.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Metformin Hydrochloride (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling changes for metformin hydrochloride; this is a regulatory action, not a clinical trial, and does not report efficacy or comparative benefit data.

AUG 11, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Fortamet (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling changes to an established metformin extended-release product; does not contain clinical trial data or efficacy evidence.